The outcome for patients hospitalized with New York Heart Association (NYHA) Class III and IV heart failure following therapy can be predicted using the clinical status and B-type natriuretic peptide (BNP) serum level. The authors are from the University of California in San Diego.

To read more or access our algorithms and calculators, please log in or register.